This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Surgeons Perform World's First Ever Cases Using IMRIS Intraoperative CT

VISIUS iCT provides on-demand access, state-of-the-art image quality during spinal procedures

MINNEAPOLIS, Oct. 31, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the spinal surgery team at Duke University Medical Center in Durham, NC, has completed the first surgical cases utilizing VISIUS iCT - an intraoperative CT that moves in and out of the operating suite on ceiling rails.

"We look forward to working with this technology," said Dr. William J. Richardson, associate chief medical officer and orthopaedic surgeon at Duke University Medical Center. "We have successfully completed complex spinal procedures and we have been pleased with the image quality. Minimizing radiation dose while providing state-of-the-art image quality is critical. In addition, the system integrates with our preferred navigation system which preserves our desired workflow."

The 64-slice VISIUS iCT scanner effortlessly moves into and out of the operating room during surgery using ceiling-mounted rails to ease workflow and provide diagnostic quality imaging at lower radiation doses. Patient transport and the need for floor-mounted rails used by other systems are eliminated - allowing unimpeded movement of surgical equipment, maintaining familiar surgical protocols, workflow and infection control procedures. The scanner can travel into two adjacent operating rooms enabling use for more patients.

VISIUS iCT provides patient personalized dose management together with diagnostic quality imaging during surgical procedures to assist surgeons in critical decision-making and procedure guidance. VISIUS iCT features a suite of software applications such as 3D volume rendering to aid in surgical planning and dose reduction algorithms which consider a patient's unique characteristics and imaging target to maximize image quality and minimize dose.

"We are excited about this initial use of the VISIUS iCT," said Jay D. Miller, IMRIS CEO and President. "With increasing usage, surgeons will discover the value of on-demand access, improved workflow, dose management, and state-of-the-art image quality with the IMRIS solution."

The Duke Medicine neurosurgery team also recently performed initial tumor removal cases using intraoperative MRI within a VISIUS Surgical Theatre installed in the hospital. The VISIUS iMRI also has the benefit of being mounted on ceiling rails so surgeons can take high-quality MR images during the procedure without moving or repositioning the patient.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 0.21%
FB $116.73 0.00%
GOOG $691.02 0.00%
TSLA $247.54 -0.07%
YHOO $36.59 0.00%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs